🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 22 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/05/2023 25,68 25,68 24,05 25,40 -2,19% 6,35% 576.100
15/05/2023 25,61 26,21 25,20 25,97 +2,36% 3,94% 693.200
12/05/2023 24,97 25,38 24,58 25,37 +2,63% 3,22% 420.200
11/05/2023 24,90 25,13 24,55 24,72 -1,20% 2,33% 462.500
10/05/2023 25,50 25,67 24,82 25,02 -0,91% 3,33% 919.500
09/05/2023 24,61 25,87 24,54 25,25 +1,28% 5,40% 695.300
08/05/2023 25,13 25,74 24,47 24,93 +0,48% 5,05% 726.600
05/05/2023 24,74 26,08 23,31 24,81 +5,13% 11,19% 1.145.000
04/05/2023 24,29 24,61 23,20 23,60 -3,48% 5,80% 490.800
03/05/2023 23,72 24,63 23,36 24,45 +3,03% 5,35% 1.535.800
02/05/2023 23,46 24,23 22,93 23,73 +0,76% 5,54% 1.414.300
01/05/2023 22,60 23,72 22,60 23,55 +4,20% 4,93% 701.300
28/04/2023 22,50 23,03 22,15 22,60 -0,31% 3,91% 736.300
27/04/2023 23,33 23,33 22,60 22,67 -2,54% 3,13% 687.000
26/04/2023 23,21 23,67 23,16 23,26 +0,04% 2,20% 625.700
25/04/2023 23,77 24,48 22,50 23,25 -2,11% 8,33% 939.100
24/04/2023 23,91 24,09 23,07 23,75 -1,12% 4,27% 597.800
21/04/2023 23,11 24,05 22,63 24,02 +3,94% 6,14% 990.400
20/04/2023 23,29 23,75 23,07 23,11 -1,49% 2,92% 890.000
19/04/2023 23,13 23,56 22,92 23,46 +1,08% 2,78% 921.800
18/04/2023 20,69 23,25 20,50 23,21 +12,56% 13,29% 1.788.900
17/04/2023 19,02 20,70 18,91 20,62 +10,03% 9,41% 1.709.200
14/04/2023 19,71 19,71 18,36 18,74 -3,95% 6,85% 719.900
13/04/2023 18,74 19,63 18,58 19,51 +4,61% 5,60% 1.000.500
12/04/2023 18,58 19,21 17,93 18,65 +1,69% 6,89% 1.289.500
11/04/2023 18,42 18,75 18,23 18,34 -0,60% 2,80% 719.700
10/04/2023 18,30 18,58 17,85 18,45 -0,11% 3,99% 1.253.200
06/04/2023 18,22 18,85 18,16 18,47 +2,50% 3,79% 1.830.800
05/04/2023 19,32 20,16 17,64 18,02 -16,38% 13,04% 5.424.500
04/04/2023 22,82 22,90 21,23 21,55 -5,57% 7,32% 518.100